Open access peer-reviewed chapter

Polydextrose in Lipid Metabolism

By Heli Putaala

Submitted: November 4th 2011Reviewed: July 23rd 2012Published: January 23rd 2013

DOI: 10.5772/51791

Downloaded: 2208

1. Introduction

Dietary fiber include fibers from natural sources (such as fruits, vegetables, and wholegrain cereals), fibers that are extracted or obtained by other means from food material, and synthetic carbohydrate polymers, that have been shown to possess physiological health benefits [1, 2]. Dietary fiber can be classified analytically as soluble and insoluble based on their solubility in water, but can also be characterized as viscous or non-viscous and fermentable or non-fermentable depending upon the physiological characteristics the fiber might have [2]. Insoluble dietary fiber includes cellulose, part of hemicellulose, and lignin, whereas soluble fibers include components such as pectin, some hemicelluloses, lignin, gums and mucilage [2, 3]. Whilst there have been difficulties in achieving a global definition for dietary fiber, it is now generally accepted that dietary fiber can be defined as carbohydrate polymers with a degree of polymerization of 3 or more monomeric units which are not hydrolysed in the small intestine by the endogenous enzymes [4]. As fiber is resistant to digestion and absorption in the human small intestine, it enters the colon where it can be partially or completely fermented [5].

Polydextrose is a polysaccharide produced by the random polymerization of glucose in the presence of sorbitol and a suitable acid catalyst, at a high temperature and under partial vacuum [6]. Polydextrose is composed of a mixture of glucose oligomers, with an average degree of polymerization ~12, but ranging from residual monomer to dp >100 [6, 7]. It is a branched molecule, and contains all different combinations of α- and β-linked 1→2, 1→3, 1→4 and 1→6 glycosidic linkages (Figure 1) [7, 8]. As polydextrose is only partially digested during gastrointestinal transit, it acts as a substrate for saccharolytic fermentation throughout the colon, even to the distal parts [9-12]. Polydextrose has a low caloric value: about 1 kcal/g, and it is widely used as a bulking agent and to replace the structure and texture of sucrose in low-calorie products by the food industry in confectionery applications, in pastry and bread, in dairy products, meat products, pasta and noodles, and in beverages [7, 13]. Polydextrose is widely accepted as a soluble fiber and has scientifically substantiated fiber characteristics, including increase in stool weight, decreased transit time, improved stool consistency and ease of defecation, and reduced fecal pH [7]. It is safe to use, and well tolerated, with a mean laxative threshold of 90 g/day, or 50 g as a single bolus dose [14-16].

Figure 1.

Structure for the polydextrose. The letter R can be either hydrogen (H), sorbitol, sorbitol bridge, of more polydextrose. Polydextrose has highly branched complex three-dimensional structure with all different combinations of α- and β-linked 1→2, 1→3, 1→4 and 1→6 glycosidic linkages.

Several beneficial effects have been linked to the consumption of polydextrose. Consumption of polydextrose promotes the growth of beneficial bifidobacteria and lactobacilli while preventing the growth of harmful ones, such as clostridia [17, 18]. It has been suggested to possess anti-inflammatory actions and to improve the signs of osteoarthritis in canines [19], to increase IgA amount in the rat cecum [20], to reduce cyclo-oxygenase 2 expression in pigs distal colon, and to reduce lesions in rat colitis model [21]. Furthermore, it has been suggested to improve the absorption of magnesium, calcium [22-25] and iron [26].

Soluble fiber, both viscous (e.g. gums, pectin and β-glucan) and non-viscous (e.g. polydextrose, resistant maltodextrin and inulin), has been suggested to have beneficial metabolic advantages. These include increasing satiety and reduction of body weight, control of postprandial glycemic and insulin responses, and hypocholesterolemic effects on serum lipid parameters [5, 27]. The inverse relationship of higher HDL to coronary artery disease risk has been recognized and is evident across numerous populations, and the increment of its relative amount over LDL has been generally accepted as a hallmark of better cardiovascular health [28]. Soluble fiber has been associated inversely with serum total and LDL cholesterol, while HDL cholesterol concentration has been reported to either slightly decrease or remain unchanged [29, 30]. This effect has been attributed as an effect of soluble viscous fibers, as insoluble fibers do not appear to affect serum cholesterol concentrations [31, 32]. The ability of soluble fibers to reduce serum triglyceride levels is also controversial, as in some studies an inverse association has been suggested, while in many studies no effect has been observed [29, 33]. Soluble viscous fibers have a characteristic of being hypocholesterolemic, reducing serum cholesterol by about 5-10 % for a 5-10 g dose in subjects with hypercholesterolemia, whereas insoluble fibers have not shown this effect [34].

2. Polydextrose studies in animals, human and in vitro: Contribution of polydextrose in lipid metabolism

Polydextrose is a fermentable non-viscous fiber, and has been shown to exhibit lipid metabolism regulating effects [5]. Typically these effects have been associated with two physiochemical properties of soluble fibers: viscosity and fermentability. Viscous soluble fibers may work by slowing down gastric emptying and prevention of bile salt re-absorption which would increase the secretion of bile acids and neutral sterols into feces and interruption of the enterohepatic circulation of bile acids [35, 36]. Soluble fiber can also decrease intestinal cholesterol absorption by affecting micelle formation and mobility [37, 38], and reduce glycemic response leading to lower insulin stimulation and hepatic cholesterol synthesis [39]. Fibers can also promote satiety [40]. Additionally, colonic fermentation products of these fibers, short chain fatty acids (SCFAs), mainly propionate, have been shown to inhibit hepatic fatty acid synthesis [41]. Polydextrose has been reported to confer lipid modulating effects in human clinical intervention studies, as well as in animal studies. However, some of the characteristics of polydextrose are different to other soluble fibers, such as low viscosity, and sustained fermentation throughout the colon [11].

2.1. Polydextrose studies in animals

The ability of polydextrose to modulate triglycerides, total, LDL, and HDL cholesterol has been studied in animals both in normal diets without additional lipid load or in diets in which lipids have been included as part of the normal diet. There is a clear difference between the types of studies, as the two studies without lipid load have not shown any effect on the blood lipid values. In a 6-week feeding study in normal rats with 5 % (w/w) inclusion of polydextrose no change in plasma triglycerides, total cholesterol, and HDL cholesterol or liver cholesterol, triglycerides and phospholipids was observed [42]. Another, 15-day feeding trial with rats, did not show differences in serum total and free cholesterol, triacylglycerols, and phospholipids even though 3 % polydextrose was administered together with 3 % pectin or 3 % cellulose [43].

However, in two other rat feeding studies in which polydextrose was accompanied with a lipid load, reduced lipid levels were reported. In one study rats were given two different dosages of corn oil, 10 % and 20 %, to represent a moderate or high fat diet, for 8 weeks, with or without 5 % polydextrose [44]. Rats in the polydextrose group showed decreased serum triglycerides as compared to a guar gum control in the high-fat diet, and increased levels of serum HDL cholesterol both in the moderate fat and high fat diet [44]. Serum total lipids and cholesterol remained at the level of the control [44]. One study has been done with gerbils: in the 4-week study the gerbils were fed with 0.15 % cholesterol with 30 % of the energy coming from fat and with inclusion of 6 % polydextrose [45]. Both liver and plasma total cholesterol as well as free and esterified cholesterol from liver decreased in the polydextrose group [45]. The effect was presumed by the authors to be related to the reduction of VLDL and LDL, since no change in HDL was observed [45]. In the same gerbil study, it was additionally investigated whether polydextrose can remove cholesterol from

Table 1.

Polydextrose studies in relation to lipid metabolism done in animals.

endogenous pools by first artificially expanding the endogenous cholesterol pools of the gerbils with a preload of 0.4 % cholesterol for two weeks before 6 % polydextrose was fed for an additional three weeks. Polydextrose was shown to hasten the endogenous clearance of cholesterol pools, and to reduce liver and plasma total cholesterol, esterified cholesterol from liver and plasma HDL cholesterol [45].

The acute response of polydextrose on serum lipid values has also been studied in rats, but together with lactitol [46]. Polydextrose was administered as a 28 % solution in a dose of 3 ml/200 g of body weight in a solution also containing 26 % lactitol and a fat emulsion which was comparable to one in chocolate. The rats showed reduced serum triglyceride levels, and an increase in luminal triglyceride levels in the cecum after 150 minutes of ingestion of polydextrose, which would indicate that the combination of polydextrose and lactitol reduced either the level of fat absorption in the earlier part of small intestine or promoted the transit time of fat through the intestine [46]. No change in total, HDL, or LDL cholesterol were found in that study.

These studies are summarised in Table 1. There is an indication from these studies that polydextrose can lower total cholesterol and has a tendency to lower LDL cholesterol and tendency to increase HDL cholesterol.

2.2. Polydextrose lipid metabolism studies in clinical intervention studies

Clinical intervention studies with polydextrose have been conducted either with healthy adults, with individuals having hypercholesterolemia or with individuals with impaired glucose tolerance.

In a human study with normal healthy adults with no reported hypercholesterolemia a reduction in the amount of total HDL by administration of 15 g of polydextrose for two months with concomitant decrease in apolipoprotein A-I, which is the main component of the HDL cholesterol, has been observed [47]. Apolipoprotein B levels, found in all atherogenic apolipoprotein particles, and the LDL cholesterol levels itself had also a tendency to be reduced after the 2-month and 1-month intervention period, respectively [47]. In another study with healthy adults, administration of 10 g of polydextrose for 18 days was shown to decrease LDL cholesterol and total cholesterol values with no effect on HDL cholesterol or triglycerides [48]. There are also contradictory results with healthy humans, as administration of polydextrose in an amount from 4 to 12 g per day for 29 days did not affect triacylglycerol, or cholesterol [49]. However, in that study no data was shown, and in addition to which the cholesterol type measured was not specified.

In hypercholesterolomic individuals, the effect of polydextrose has been studied in a 4-week study with administration of 15 g and 30 g polydextrose daily [45]. The study was quite small, with only 12 subjects participating, and each individual subject serving as a control for him/herself. In this study it was noted that 5 of the 6 individuals ingesting 30 g of polydextrose were in a separate responder group, and in this group the LDL cholesterol values declined significantly, and there was a tendency for reduced total cholesterol, but no change in HDL cholesterol. However, when all 6 individuals were studied together, no change compared to control was observed.

In diabetic patients, diets containing high amounts of fiber have improved plasma lipid control [50, 51]. The effect of polydextrose on lipid values has been of interest in two studies with individuals showing abnormal glucose metabolism or type 2 diabetes. In subjects with impaired glucose metabolism, polydextrose administered for 12 weeks at 16 g/day has been observed to lower LDL cholesterol, increase HDL cholesterol and cause no change in triglycerides [52]. In this study, LDL cholesterol decreased also in the control group probably because of simultaneous nutrition consultation by a nutritionist [52]. In a combination study with 7 g polydextrose and 3 g oligofructose administered daily for 6 weeks in adults with type 2 diabetes, a decrease in total cholesterol, triglycerides, VLDL cholesterol, and ratios of total cholesterol to HDL cholesterol, and LDL cholesterol to HDL cholesterol was observed, while HDL cholesterol increased [53].

The acute effect of polydextrose has been studied in humans too, together with lactitol, in the triglyceride levels after consumption of 46 g of chocolate supplemented with 15.1 % of the weight with polydextrose. The intervention group had reduced serum triglycerides in comparison to control chocolate during the 150 minutes the triglycerides were measured from the blood [46]. During intense exercise, polydextrose has been shown to reduce the amount of free fatty acids in plasma [54]. In addition, an abstract has been published about ingestion of 12.5 g polydextrose during a hamburger meal observing a reduction in total postprandial hypertriglyceridemia by 25 % [55].

2.2.1. Effect of polydextrose on different HDL subfractions

HDL is highly heterogeneous, and subfractions of it can be identified on the basis of density, size, charge, and protein composition [56]. Different fractions of HDL can be identified by ultracentrifugation, gradient gel electrophoresis, and nuclear magnetic resonance (NMR) spectroscopy, and these different fractions could play diverse roles in protective function [56, 57]. It is thought that certain fractions of HDL cholesterol could be better predictors of cardiovascular diseases and its risk. However, controversy about the role of the different forms still exists, as in [58] and in [59] increased HDL2 and apoA-I levels were associated as protective against coronary heart disease. In other studies, in turn, such as in [60], and [61], the HDL3 has had a stronger inverse association with coronary heart disease. The early studies, however, more strongly indicate that reduced levels of HDL2 over HDL3 is associated more strongly to CVD risk [62].

The different subfractions of HDL and the impact of ingestion of polydextrose on their distribution has been investigated in one study [47], and in this study HDL3 was increased during the 2-month intervention period and one month after finishing the study. At the same time, a reduced level of HDL2, apoA-I and LCAT activity was observed. In other studies with soluble fibers, such as with guar gum, no changes in HDL2 and HDL3 subfractions or their ratio were observed [63, 64]. No difference between serum HDL2 and HDL3 cholesterol subfractions could be observed between high-fiber, consisting partially of soluble fiber from psyllium, and low-fiber diets [65] or with beta-glucan as an oat fiber extract [66]. In addition, lack of standardization among the analytical methods that are used to measure size distribution of different HDL2 and HDL3 subfractions may cause approximation of HDL subclass levels [67, 68].

Table 2.

Polydextrose clinical intervention studies in which lipid values have been measured.

Table 2 summarizes the different human clinical intervention studies done with polydextrose in relation to HDL, LDL, total cholesterol and triglycerides. From these studies it can be concluded that polydextrose in the diet can lower serum total and LDL cholesterol and triglycerides. There are two studies in which definite increases in HDL have been observed.

3. Mechanisms for polydextrose action on lipid values

3.1. Role of polydextrose in enterohepatic bile circulation and in cholesterol absorption

One of the mechanisms by which soluble viscous fibers induce hypocholesterolemic responses is the disruption of enterohepatic bile acid circulation, which reduces absorption of intestinal bile acids. The major route by which cholesterol in the liver is eliminated is through the de novo synthesis of primary bile acids from cholesterol [70]. The bile is released into the small intestine, where bile salt micelles help in the solubilisation of lipophilic components, such as cholesterol, fat soluble vitamins, and other lipids [70]. The diffusion of the micelles with solubilised components as well as the biliary and dietary cholesterol across the unstirred water layer, covering the luminal side of the enterocytes facilitate the uptake of cholesterol and other lipophilic components by the enterocytes [71]. When the bile salt micelles have accomplished their role they transit the remainder of small and large intestine where they are progressively absorbed into the enterohepatic circulation by the hepatic portal vein [70]. The bile salts that escape the intestinal absorption are transformed through colonic bacterial enzymatic activity to form secondary bile salts, from which deoxycholic acid is absorbed passively through colonic epithelium into the enterohepatic circulation, while lithocholic acid is secreted into the feces [72]. The amount of bile salts, both primary and secondary, is maintained in a rather constant level, and the daily bile salt losses are compensated by de novo hepatic biosynthesis [73]. The enterohepatic circulation is very efficient, as 95 % of the bile salts released into the intestine is absorbed back to the liver [70].

The presence of viscous soluble fiber has been shown to prevent bile salt reabsorption, which leads to enhanced excretion of bile salts into feces [35, 36]. This depletes the bile acids from liver and leads to rapid catabolisation of cholesterol through activation of 7alpha-hydroxylase. At the same time cholesteryl esters are metabolised, and in order to replace these production of LDL surface membrane receptors and concomitant LDL cholesterol uptake from blood stream are increased. This leads to lowering of the blood cholesterol concentration [74]. The fibers presumably interact with bile acids directly at the molecular level or entrap bile salt micelles in the gelatinous network formed by the polymeric fiber [35, 75]. The fiber can also form a barrier which can prevent the formation of bile acid micelles, and increase the unstirred water layer lining the intestinal mucosal surface [76].

Polydextrose is a non-viscous fiber and its capacity to bind bile salts has been studied in one clinical intervention study [77]. In this study, administration of polydextrose in healthy adults at 8 g/day for three weeks was not found to increase fecal excretion of total bile acids and secondary bile acids, but rather decreased values were observed during the intervention period compared to the run-in period before [77]. A similar observation was made in normal rats, in which administration of 5 % polydextrose for 6 weeks did not increase the fecal output of bile acids [42]. The low ability of polydextrose to bind bile acids is not, however, surprising. In order for a fiber to bind bile acids, it is required to be viscous in nature, and polydextrose is lower in viscosity for instance in comparison to pectin and guar gum which have high water binding capacity with higher viscosity and thus increased capability to bind bile acids [42, 78]. Polydextrose has a high capacity to bind water, and it can for instance relieve constipation presumably due to this characteristic, but there is no gel formation by polydextrose in water and little viscosity [43, 79, 80].

Even though no clear effect on bile acid binding can be detected, the fact that cholesterol and triglyceride absorption can still be modulated, are indications that polydextrose can retard the transportation of lipids from the intestinal lumen to the lymph. When polydextrose was infused as 5 % and 10 % to duodenum together with cholesterol and triglyceride on mesenteric lymph-fistulated rats, the amount of cholesterol and triglycerides in the lymph decreased dose-dependently, and concomitantly the amount of the unabsorbed lipids increased in the lumen of the intestine [81]. It was concluded that since most of the luminal triglyceride and cholesterol was detected in the proximal part of the small intestine, the absorption of the lipids was inhibited. There was a tendency to have increased amount of cholesterol and a significant increase of triglycerides remaining in the colon which could indicate that some of the lipids were not absorbed [81]. However, polydextrose did not seem to increase secretion of cholesterol into feces in rats even though some tendency was observed in another study [82].

In an acute response study of polydextrose in combination with lactitol in rats with lipid load similar to the composition of chocolate an increase in luminal triglyceride in the cecum was observed with concomitant decrease in serum triglycerides [46]. This would indicate that the combination of polydextrose and lactitol reduced either the level of fat absorption in the earlier part of small intestine or promoted the transit time of fat through the intestine [46].

Cholesterol that escapes absorption is partially degraded to coprostanol and coprostanone by colon microbes [83]. A decrease of the degradation products coprostanol, coprostanon and cholestanol has been observed [77] which would indicate that the amount of cholesterol entering the colon is less in humans receiving polydextrose.

3.2. Role of polydextrose on intestinal microbiota and its impact on cholesterol metabolism

When soluble fiber enters the large intestine, it is fermented by the residual microbes forming short-chain fatty acids (SCFAs), butyrate, acetate, and propionate, end-products of bacterial carbohydrate fermentation. The SCFAs have been indicated to possess different physiological functions. Butyrate has been implicated to be the most important SCFA for colonic and immune cells due to its ability to serve as energy source for colonic epithelium as well as regulate cell growth and differentiation [84, 85]. It is a preferred energy source by colonocytes over glucose, glutamine, or other SCFA, and 70 to 90 % of butyrate is metabolized by colonocytes [86]. It has been implicated to inhibit intestinal cholesterol biosynthesis [87]. Acetate, as a direct substrate for acetyl-CoA synthetase, an enzyme that converts acetate to acetyl-CoA for entering to the cholesterol and fatty acid synthesis cycle, has been implicated to increase liver cholesterol, and fatty acid levels [41, 88]. Acetate has been shown to associate negatively with visceral adipose tissues and insulin levels in obese people [89]. Propionate has been shown to possess antilipogenic and cholesterol-lowering effects. While acetate is a substrate for sterol and fatty acid synthesis, propionate counteracts this by inhibiting acetate incorporation to serum lipids [41]. Propionate has been shown to to reduce the rate of cholesterol synthesis [87, 90], to inhibit fatty acid synthesis [91], to decrease liver lipogenesis [92], and to decrease hepatic and plasma and serum cholesterol levels [93, 94]. Propionate supplementation has been shown increase serum HDL cholesterol and triglyceride levels without effect on total cholesterol [92, 95]. However, contradictory results about its efficacy on cholesterol metabolism has been also observed [96-98].

The production of short-chain fatty acids during polydextrose fermentation has been studied with batch fermentations, colon simulators as well as from feces in animal and human studies. The differences in the results reflect individual variation, sampling, and differences in the methods used. Fecal SCFA concentration measurements are not the best indicators of SCFA produced as the majority of fecal SCFA is absorbed rapidly by the colonic epithelial cells [99]. Polydextrose has been observed to increase the production of butyrate, acetate and propionate in vitro [18, 100-102], in rats [20], pigs [11], in dogs [103] and in humans [17, 49]. When compared to other fibers, polydextrose produced similar quantities of SCFAs, and the molecular ratio of acetate/propionate/butyrate produced was found to be similar to that of fructo-oligosaccharides and xylo-oligosaccharides and other carbohydrates, such as inulin, pectin, and arabinose [104, 105] while in other studies polydextrose produced less total SCFAs compared to FOS, inulin and GOS [102, 106, 107]. The lower production of SCFAs by polydextrose can be explained by the lower digestability of polydextrose and its more sustained fermentation throughout the gut due to its branched complex structure. Furthermore, polydextrose fermentation has been shown to reduce putrefactive microbial metabolites, or branched-chain fatty acids and biogenic amines produced from protein fermentation [11, 20, 49, 100, 101, 107-109] but the decrease of these in relation to lipid metabolism and absorption is unknown. Figure 2 shows an example of how fermentation of polydextrose increases the amount short chain fatty acids in an in vitro colon simulation both when the amount of polydextrose is increased, and when the simulation proceeds from vessel V1 representing proximal part of the colon towards the vessels representing more distal parts of the colon [108].

Figure 2.

Concentration (mM) of short chain fatty acids (SCFAs) in the different vessels V1, V2, V3, and V4 after 48h in vitro colon fermentation simulation. An increase in the concentration of SCFAs can be observed both dose-dependently as well as from vessels representing proximal colon V1 towards vessels representing more distal parts of the colon, V3 and V4.

When polydextrose enters the colon, it is fermented by the indigenous microbiota, thus serving as an energy-source to promote their growth and survival. In germ-free mice, the transplantation of the colonic microbiota from normal mice resulted in a 60 % increase in body fat in an unchanged diet [110] and there are an increasing number of reports that the gut microbiota may play an important role in cholesterol and lipid homeostasis, in obesity and metabolic syndrome [111-113].

Bacterial DNA of fecal samples from 20 individuals consuming 21 g of polydextrose in 3 doses per day were pyrosequenced, and the amount of Clostridiaceae, and Veillonea increased while Lachnospiraeae and Eubacteriaceae decreased compared to the control group without additional supplemental fiber [114]. Well-known butyrate-producers were increased in number, such as Faecalibacterium, and especially Faecalibacterium prausnitzii, whereas other SCFA producers, such as Lachnospiraceae, and Eubacteriaceae were reduced in number by administration of polydextrose [114]. Polydextrose also decreased the number of Coriobacteriaceae, which have been shown to have a positive association to non-HDL cholesterol [111, 114]. Interestingly, bifidobacteria have shown a positive correlation with HDL-cholesterol [111], but the bifidobacterial counts were decreased by polydextrose when studied with pyrosequencing [114]. In other studies polydextrose administration has been shown to increase the amount of bifidobacteria and lactobacilli [17, 18, 49, 106, 107, 115] while in some studies this effect has not been noted [103] or that there was no effect on the growth of lactobacilli [102]. This kind of inconsistency in the response could reflect the interindividual differences in indigenous microbiota to begin with. These kind of fluctuations in the indigenous microbiota, however, might explain why there are differencies in the studies with polydextrose and its effect on cholesterol values, for instance in [45] in which a responder group with a decrease in LDL was observed.

3.3. Polydextrose effect on glycemic control and insulin response

Fibers can affect blood glucose levels by decreasing the glycemic load of a meal or by affecting glucose absorption or release of glucose [5], and especially soluble fiber has been shown to attenuate the absorption of glucose [27]. Soluble dietary fibers may affect total and LDL cholesterol levels through effects on postprandial glycemia, as reduction in the glucose absorption, which would lower the insulin level and its production in the pancreas, would then lead to a decrease in cholesterol synthesis [116]. When soluble dietary fibers are being digested they delay the emptying of digested food from the stomach to the small intestine, slow down the transportation and mixing of digestive enzymes in the chyme and increase the resistance of the unstirred water layer lining the mucosa [117, 118]. This leads to reduction in the absorption of glucose and macronutrients, and lowered level of postprandial glucose is accompanied with lowered insulin level which would possibly lead to lowered hepatic cholesterol synthesis. [39]. There has been studies describing inverse relationship between glycemic load and HDL cholesterol [119, 120], and an indirect regulation of intestinal lipid uptake by dietary glucose has been presumed. Short-term incubation with intestinal epithelial cells, Caco-2 cells, with glucose on the apical side induces a significant uptake of cholesterol in a dose-dependent manner [121], and in addition cholesterol synthesis seems to dependent on glucose intake [122].

The effect of polydextrose ingestion on glucose and postprandial insulin response has been investigated in several studies. Polydextrose has a very low glycemic index (4 to 7) with glycemic load of 1 compared to the reference glucose (100) [7, 123]. Polydextrose has been reported to attenuate the blood glucose raising potential of glucose, as the glycemic index of glucose was reduced from 100 to 88 when 12 grams of polydextrose was ingested together with glucose by healthy adults [49]. Similar results were observed in a study with healthy adults when 14 g was ingested together with 50 g of glucose or 106 g of bread [124]. Plasma glucose levels were decreased by 28 % and 35 %, compared to glucose and bread without polydextrose, respectively, with significantly reduced serum insulin levels in the glucose plus polydextrose group [124]. These observations indicate that polydextrose could reduce the absorption of glucose. When the effect of polydextrose was studied with human subjects with impaired glucose tolerance or impaired fasting glucose, no change in plasma glucose or insulin has been observed [52]. However, this study [52] had a moderately high fructose intake which could have affected the results as fructose does not induce endogenous secretion of insulin [125]. Diurnally polydextrose did not seem to change plasma sugar levels, but a decrease in insulin after meals was noted [69]. In dogs, polydextrose showed an attenuated postprandial glycemic and lower relative insulin responses than the control sugar maltitol [126].

Polydextrose has been also studied in trials in which the reference group received a normal meal/snack with glucose, and the intervention group the same but with the glucose partially replaced with polydextrose. In volunteers with type 2 diabetes, cranberries with 10g of polydextrose showed attenuated plasma glucose and insulin response compared to cranberries with glucose [127]. In one study with healthy adults, significantly lower postprandial glucose levels were observed after ingestion of strawberry jam with 40 % polydextrose than after ingestion of strawberry jam sweetened with sugar, corn syrup, or apple juice, but this study did not measure insulin [128].

These above results indicate that polydextrose might have a role in postprandial glucose absorption and insulin response. One good candidate to modify insulin response is again the SCFAs, especially propionate, which have been shown to improve insulin sensitivity during glucose tolerance tests [95]. Polydextrose also might interfere the release and absorption of the glucose in the small intestine which would lead to slower and lower blood sugar rise [5]. In some of these studies the response is observed because polydextrose was used as sugar substitute to lower the caloric content of the snack/product [127, 128]. In [127] the beneficial insulin reduction was observed not to be in 1:1 ratio with caloric reduction so there might be additional beneficial effect apart from lowering the overall calorie content.

3.4. Polydextrose as a satiety increasing agent

Meals dense in fiber have also been demonstrated to be able to control the sense of hunger, satiety, inhibit the desire for another meal, or induce satiation, limit the size of the meal, possibly by lowering caloric density or slowing down gastric emptying [40, 129] This would further decrease the sugar load of the individual, since high-fiber diets usually have a lower glycemic load.

Polydextrose has been observed to significantly reduce the feeling of hunger in subjects with impaired glucose metabolism [52], and to have tendency towards reduced snacking [10]. It has been shown to increase satiety and to reduce food intake when combined with yoghurt preloads [130]. However, evidence has been conflicting - in one study when 25 g polydextrose was preloaded in two servings before lunch, no difference in the desire to eat, sense of hunger and fullness was observed beween polydextrose and the other fibers tested [131]. In this study polydextrose did not decrease the energy consumed in lunch. In another study when polydextrose was consumed as 9.5 g in a muffin no difference in the feeling of hungriness or food intake was observed between polydextrose and the other fibers studied [132]. In the two most recent studies, polydextrose intake of 12 g in a fruit smoothie, consumed as a single dose preload, significantly reduced the intake of energy in a buffet lunch 1 hour after the consumption of the smoothie [133]. Similar observations with a single dose of 6.25 g or 12.5 g of polydextrose before a test lunch were also made in another study [134, 135].

Both butyrate and propionate have been shown to induce gut hormones and reduce food intake [136]. Propionate has been shown to act as a satiety-inducing agent, with strong effects on energy intake and feeding behaviour with significantly greater feeling of fullness and lower desire to eat [137, 138]. This could be introduced by the modulation of the colonic mucosa secreted peptide hormones that regulate appetite, such as glucagon like peptide -1 (GLP-1), peptide YY (PYY), oxyntomodulin, or SCFA receptors, GPR43 or GPR41, which have been localized in intestinal enteroendocrine L cells, that are responsible for the production of the appetite regulating hormones [139, 140] but whether polydextrose ingestion causes changes in these peptide hormones remains to be investigated.

3.5. Modulation of genes regulating energy metabolism by polydextrose fermentation in colon

Microbial metabolites have been shown to modulate gene expression, for instance butyrate acts as a histone deacetylase (HDAC) inhibitor, and affects gene transciption [141]. Polydextrose has been shown to increase expression of PPARγ in the colon of mice [142]. This has been attributed to be mediated at least by butyrate, which can not only up regulate gene expression of PPARγ, but also activate it [143]. When intestinal epithelial cells were treated with polydextrose fermentation metabolites, a gene expression signature was induced that approached the response of butyrate [144]. In the study [144] 1 or 2 % polydextrose was fermented in a four-stage semicontinuous colon simulation model, in which each vessel in sequence represents different parts of the colon. Caco-2 cells were treated with the polydextrose fermentation metabolites from each vessel, and the idea was to analyse gene expression pattern of the Caco-2 cells treated with fermentation metabolome representing the whole colon. The weakness of this study was that the cells were not differentiated, but were used as a cancer cell model, and that fermentation metabolites originated from a fecal sample only from one individual. In the gene ontology analysis of this study, enrichment of class "lipid metabolism" by the polydextrose fermentation metabolites was noted, which indicated that genes involved in energy metabolism were regulated. Indeed, induction of PPARα, PGC-1α, and Lipin 1which are major regulators of the metabolism, were observed. Additionally, some PPARα responsive genes were observed to be up regulated, such as SORBS1, LPIN1, NPC1, FATP1, HMOX1, and ACSL1 [144].

In the intestine, activation of PPARα results in the specific induction of genes involved in fatty acid uptake, binding, transport, and catabolism. In addition, genes involved in triacylglycerol and glycerolipid metabolism have been suggested to function as fatty acid sensors, and in nutrient absorption [145, 146]. PGC-1α participates to the regulation of both carbohydrate and lipid metabolism, and it has been involved in the adaptation of and maintenance of energy homeostais in caloric restriction [147]. Drosophila PGC-1α homolog increases mitochondrial gene expression and activity and protects against age-related loss of intestinal homeostasis and integrity, and is suggested to extend life span [148]. Lipin 1 is induced by PGC-1α in liver and acts to amplify PGC-1α and to activate many of the genes of mitochondrial fatty acid oxidative metabolism [149]. Lipin 1 has been associated with insulin sensitivity in adipose tissue and liver which indicates that it has a profound role in maintaining systemic metabolic homeostasis [150, 151].

One of the genes regulated by polydextrose fermentation metabolites was Niemann Pick C1 (NPC1), a significant contributor to plasma HDL cholesterol formation [152]. NPC1 facilitates the movement of cholesterol to ABCA1, a cholesterol transporter that is located in the basolateral membrane of enterocytes, that is involved in the efflux process of cholesterol to circulating HDL particles [153]. Approximately 30 % of the steady-state HDL was contributed by the intestinal ABCA1 in mice [154]. In NPC1 deficient cells the HDL cholesterol formation is reduced [155].

4. Conclusions

Based on the current research there is clear evidence that polydextrose has the ability to attenuate glucose absorption, reduce insulin response and lower blood LDL, total cholesterol and triglyceride levels. HDL cholesterol shows a tendency to be increased, but this has not been consistently demonstrated in all studies. This kind of ability to increase HDL would be quite unique among soluble fermentable fibers. Animal studies also indicate that polydextrose could interfere with cholesterol and triglyceride absorption.

Figure 3 summarises the possible mechanisms of how polydextrose could affect cholesterol and lipid metabolism. Polydextrose is used as a bulking agent, and increases the bulk of the material that transits along the colon. This can provide a sense of fullness and satiety. The effect of polydextrose on bile acid secretion cannot be definitely concluded at this point but is unlikely due to its non-viscous characteristic. It seems, that polydextrose attenuates the blood glucose raising potential of glucose itself, and the insulin response. Glucose and insulin are linked to hepatic de novo cholesterol synthesis, cholesterol absorption and HDL formation. The mechanism of the lipid metabolism modulating effect of polydextrose might be indirect, through its fermentation by the indigenous microbiota either the luminal or mucosal, that at the same time increase SCFA production. The microbiota can affect cholesterol degradation, but could also for instance affect chylomicron formation and cholesterol absorption. The absorbed SCFAs, propionate and butyrate, are linked to diminishing de novo cholesterol synthesis in the liver. Acetate, in contrast, has an opposite effect. Whether SCFAs are the molecules exerting the effect of the polydextrose is not known. During the fermentation of soluble fibers other metabolites apart from SCFAs are formed [156]. The complex structure of polydextrose facilitates its fermentation throughout colon. This differentiates it from other fibers which are fermented early in the colon, and it serves as an energy source for bacteria throughout the colon, and changes in the composition of the microbiota are observed with an increase in butyrate-producing bacteria [114]. It is possible that due to its fermentation characteristics the long-term effect on microbiota composition might be different to other soluble fibers. The mechanism of polydextrose might also be direct, through modulation of surface receptors, but currently there is no evidence for this.

The microarray study has given ideas of how polydextrose fermentation metabolites might affect the intestinal tissue. The evidence is, however, at the transcriptional level only, and is speculative. Additional studies in the possible regulation of PPARα, PGC1α, Lipin1, NPC1, and others by polydextrose is thus needed. In vitro studies could be used for instance to study the role of polydextrose fermentation in HDL formation using a differentiated Caco-2 cell model which has shown to be good model to study de novo ApoA-I production [157].

Figure 3.

Summary of the polydextrose function in lipid metabolism.

It could be worthwhile to investigate to what extent polydextrose fermentation metabolites cause systemic effects for instance in liver, and its de novo cholesterol synthesis, not forgetting the role of the intestine. When lipidemic conditions are normal, the liver is the most important site of cholesterol biosynthesis, followed by the intestine. Biosynthesis in the liver and intestine account for about 15 and 10 %, respectively, in the total amount of cholesterol biosynthesis each day [158] [159]. In hypercholesterolemia, when cholesterol biosynthesis is supressed in most organs by fasting, the intestine becomes the major site of cholesterol biosynthesis, and its contribution can increase up to 50 %[160, 161]. Mixtures of short chain fatty acids have been show to suppress cholesterol synthesis in the rat liver and intestine [162], and whether fermentation metabolites from polydextrose can inhibit cholesterol biosynthesis in the intestine, or even in the liver, is an open question.

Acknowledgement

Michael Bond, Stuart Craig, and Kirsti Tiihonen (DuPont Nutrition and Health) are thanked for their valuable contribution on the manuscript.

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Heli Putaala (January 23rd 2013). Polydextrose in Lipid Metabolism, Lipid Metabolism, Rodrigo Valenzuela Baez, IntechOpen, DOI: 10.5772/51791. Available from:

chapter statistics

2208total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Spent Brewer’s Yeast and Beta-Glucans Isolated from Them as Diet Components Modifying Blood Lipid Metabolism Disturbed by an Atherogenic Diet

By Bozena Waszkiewicz-Robak

Related Book

First chapter

Non-alcoholic Fatty Liver Disease: What We Learn from Omics Studies

By Seyma Katrinli, Kamil Ozdil, Gizem Dinler-Doganay and Levent Doganay

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us